Lanham Act plaintiffs seeking preliminary injunctive relief are not entitled to a presumption of irreparable harm, the U.S. Court of Appeals for the Third Circuit held Aug. 26.

The precedential decision in Ferring Pharmaceuticals v. Watson Pharmaceuticals upheld a lower court’s refusal to halt the use of advertising that allegedly contains false and misleading statements about a competing product.